Presentation TCT 2018 Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction? Presenter: Renu Virmani, Clemens von Birgelen, David E. Kandzari September 22, 2018
Presentation TCT 2018 Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)? Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner September 22, 2018
Presentation TCT 2017 Case #6 (With Discussion): STEMI and an Intact Fibrous Cap Presenter: Henning Kelbæk, Renu Virmani, Ik-Kyung Jang November 01, 2017
Presentation TCT 2017 Case #5 (With Discussion): Spontaneous Coronary Artery Dissection Presenter: Henning Kelbæk, Renu Virmani, Adriano Caixeta November 01, 2017
Presentation TCT 2017 Case #4 (With Discussion): A Patient With STEMI and Multivessel Disease Presenter: Henning Kelbæk, Renu Virmani November 01, 2017
Presentation TCT 2017 State-of-the-Art Review: Intravascular Imaging and Physiology in ACS - Culprit Lesion and Vulnerable Plaque Assessment Presenter: Henning Kelbæk, Renu Virmani, Francesco Prati November 01, 2017
Presentation TCT 2017 Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Renu Virmani November 01, 2017
Presentation TCT 2017 TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry Presenter: Francesco Prati, Renu Virmani, Yoshinori Nagasawa, MD October 31, 2017
Presentation TCT 2017 TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry Presenter: Francesco Prati, Renu Virmani, Antonio Colombo October 31, 2017
Presentation TCT 2017 TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings Presenter: Francesco Prati, Renu Virmani, Abraham Tzafriri, MD October 31, 2017
Presentation TCT 2017 Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES? Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani October 30, 2017
Presentation TCT 2017 Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani October 30, 2017
Presentation TCT 2017 Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations Presenter: Christopher B. Granger, Horst Sievert, Renu Virmani October 30, 2017
News Industry News Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial September 05, 2017
Presentation TCT 2016 Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing I: Pathologic Perspectives Presenter: Elazer R. Edelman, Juan F. Granada, Renu Virmani October 31, 2016
Presentation TCT 2016 Potential Advantages and Pitfalls of Bioabsorbable Polymers Presenter: Stephan Windecker, Renu Virmani October 31, 2016
News Conference News TCT 2016 DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term Todd Neale October 30, 2016
Presentation CCVVC 2016 Pathology of Drug Eluting Technologies: Are There Differences? Presenter: Renu Virmani June 15, 2016
Presentation CCVVC 2016 Calcium in the Peripheral and Coronary Arteries: The Pathologist View Presenter: Renu Virmani June 15, 2016